Key Highlights

  • Oracle (NYSE:ORCL) priced USD 20 billion of securities on November 2, 2026: 86,206,897 common shares at USD 116.00 for net proceeds of about USD 9.9 billion, plus USD 10.0 billion of senior notes.
  • The notes carry coupons from 7.000% to 8.650%, with tranches reported for 2029, 2031, 2033, 2037 and 2046, and both offerings are expected to close on November 4, 2026.
  • The Offer Price of USD 116 is about 2.7% below the USD 119.20 close on November 2, simple arithmetic on two published numbers, after shares fell about 8.6% that day.
  • Oracle said proceeds are for general corporate purposes, which may include capital expenditures and Debt repayment, while it affirmed about USD 70 billion of full-year capital spending.

The Terms of the Raise

Oracle (NYSE:ORCL) split the raise evenly between Equity and debt. The common stock sale of 86,206,897 shares at USD 116.00 is worth about USD 10.0 billion before costs, which matches the roughly USD 9.9 billion of net proceeds. The five note tranches priced between 7.000% and 8.650%, the high end applying to the longest Maturity in 2046. Those coupons are high for a large technology issuer, which shows how much the market is charging to fund AI Data Center spending. The release lists no mandatory convertible and does not describe an underwriters' option. Oracle shares fell about 8.6% in the regular session on November 2, after the offering was first announced, while reports of that day's drop ranged from 5% to 9%.

Why Dilution and Funding Costs Matter

New shares dilute existing holders, and a USD 116 price that sits about 17.9% below the 50-day average of USD 141.25 shows the discount investors demanded. The stock is down roughly 38% for the year and was described as near an 18-month low in one report. Oracle reported fiscal first-quarter Revenue up 30% to USD 19.35 billion and a Backlog of USD 664 billion, so Demand is not the issue. The issue is paying for capacity before revenue arrives. Moves after pricing were reported inconsistently, from 0.2% overnight to a gain of 5.9% on November 3, so no single figure should be treated as settled. The USD 70 billion spending plan is large against the USD 20 billion raised, so more funding may follow.

Risks and What to Watch

Higher interest costs reduce free cash flow, and customer concentration in a small number of large AI contracts adds risk if any of them slips. Oracle (NYSE:ORCL) has also signalled larger plans, with published coverage citing a target of up to USD 50 billion of debt and equity in 2026. Watch the closing on November 4, the next quarterly update on capital spending and any change in Credit ratings. For benchmark context, the Nasdaq Composite fell 1.07% on November 2 and the S&P 500 fell 0.51%, a day when AI-linked shares were broadly weak. Interest on USD 10.0 billion at coupons of 7.000% to 8.650% implies an annual cost near USD 0.8 billion, simple arithmetic assuming an average coupon near 8%.

Where Things Stand

Oracle (NYSE:ORCL) is raising USD 20 billion because its AI buildout, with about USD 70 billion of planned capital spending, needs funding ahead of the revenue in its USD 664 billion backlog, and it chose a mix of stock and debt. The cost is visible in an offer price about 2.7% below the prior close and coupons up to 8.650%. The risks are dilution, higher interest expense and execution. Watch the November 4 closing and the next capital spending guidance.